Cervantes A
机构: Professor of Medicine. University of Valencia
每年引用次数
引用次数
引用: 59,112
H-指数: 103
I10-指数 : 327
出版物: 906
Esfuerzo triaxial ideal de Ti, Zr y Hf con estructura fcc: un estudio de primeros principios
E. Chigo Anota , M. Salazar Villanueva , J. H. Camacho García , A. Macias Cervantes
Revista Mexicana De Fisica 57 ( 2) 140 -145
3
2011
Theoretical study on small clusters of BaTiO3 using DFT calculations
M. Salazar-Villanueva , A. Bautista Hernandez , E. Chigo Anota , J.I. Rodríguez Mora
Molecular Simulation 39 ( 7) 545 -549
4
2013
Abstract B154: A first-in-human trial of GDC-0068: A novel, oral, ATP-competitive Akt inhibitor, demonstrates robust suppression of the Akt pathway in surrogate and tumor tissues.
Yibing Yan , Marie-Claire Wagle , Elizabeth Punnoose , Luna Musib
Molecular Cancer Therapeutics 10
15
2011
Estrogen and progesterone receptors in cancer of the breast
Alberola , Artero A , García Conde J , Barrajón G
Medicina Clinica 89 ( 11) 456 -459
1987
Treatment of locally advanced cancer of the breast
Alberola , Lluch A , García-Conde J , Martínez Agulló A
Medicina Clinica 89 ( 1) 7 -10
1987
The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
E Aranda , A Cervantes , A Carrato , A Antón-Torres
The Journal of infusional chemotherapy 6 ( 3) 118
2
1996
Randomized Phase 3 Study of Panitumumab With FOLFIRI vs. FOLFIRI Alone as Second-Line Treatment in Patients With Metastatic Colorectal Cancer
Gansert J , André T , Peeters M , Rong A
Gastrointestinal Cancer Research : GCR
25
2010
Cámaras ocultas en la Pirámide del Sol
R Alfaro , E Belmont Moreno , Azucena Cervantes , VS Grabski
Investigación y ciencia ( 372) 62 -71
2007
A muon detector to be installed at the pyramid of the sun
A. Martinez-Davalos , E. Belmont-Moreno , L. Manzanilla , R. Alfaro
Revista Mexicana De Fisica 49 ( 4) 54 -59
6
2003
Cetuximab plus oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) for the epidermal growth factor receptor (EGFR)expressing metastatic colorectal cancer (mCRC) in the first-line setting: a phase II study
A. de Gramont , Emmanuel Van Cutsem , J. Sastre , A. Cervantes
Ejc Supplements 3 ( 2) 181 -182
17
2005
Updated survival analysis of EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab in MRI-defined high risk rectal cancer patients
I. Chau , F. Sclafani , Bengt Glimelius , D. Gonzalez De Castro
European Journal of Cancer 49
2
2013
Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
J. M. Del Campo , A. Poveda , A. Cervantes , B. Massuti
Seminars in Oncology 24 ( 5)
1997
441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
A. Dowlati , M.A. Huseni , S. Gettinger , V.M. Villaflor
Annals of Oncology 27
25
2016
TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial
I. Chau , F. Sclafani , B. Glimelius , S.H. Wilson
European Journal of Cancer 49
7
2013
AGENTES INDUCTORES DE LA DIFERENCIACION. SU VALOR EN EL TRATAMIENTO ANTITUMORAL
H. M. Pinedo , A. Cervantes , A. Leyva , G. Schwartsmann
Anales De Medicina Interna 4 ( 1) 1 -2
1987
Checkpoint inhibitors for gastroesophageal cancers: Dissecting heterogeneity to better understand their role in first line and adjuvant therapy.
V. Gambardella , V. Gambardella , E.C. Smyth , A. Cervantes
Annals of Oncology 32 ( 5) 590 -599
83
2021
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines.
P. Schirmacher , B. Sangro , C. Verslype , I. Chau
Annals of Oncology 32 ( 6) 801 -805
143
2021
In the literature: February 2021.
V. Gambardella , V. Gambardella , A. Cervantes , T. Fleitas
ESMO Open 6 ( 2) 100061 -100061
2021
P0304 / #439: A NOVEL INTERVENTION TO SUPPORT STAFF IN THE PEDIATRIC INTENSIVE CARE UNIT - SCHWARTZ CENTER ROUNDS
S. Razack , F.A. Carnevale , A. Cervantes , M. Ruddy
Pediatric Critical Care Medicine 22 167 -167
2021